“With companies like Pfizer (NYSE:PFE) giving possible hope for an end of year vaccine and a recent gap up in IBB (Nasdaq Biotechnology ETF), now could be a good time to keep an eye on newer issues in this sector,” advises the author of today’s article. She proceeds to highlight three specific newer biotech companies to watch for potential trade opportunities. For more, CLICK HERE.